Search the Newsreel

Arvee Laboratories (India) Ltd is Rated Strong Sell

Arvinas Inc (ARVN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Arvinas Inc (ARVN), indicating its current earnings forecast score, average price target, and analyst ratings. Based on 17 analysts, the stock has a "Buy" trend with a target price of $14.00, suggesting a potential upside of 61.90%. …

Aarvi Encon Ltd. Earnings and Revenue – BSE:AARVI

Marvell Shares Rise 4% After Key Trading Signal

Marvell Technology (NASDAQ: MRVL) shares rose 4.10% intraday after triggering a Power Inflow signal, a bullish indicator based on order flow analytics from TradePulse. The signal, which detects significant shifts towards buying activity from both retail and institutional traders, was issued at 10:52 AM …

Claude AI’s Newest Stock Picks Are Also Hedge Fund Favorites: One Breakout Biotech, One AI Chip Bet

Note: the trade details cited in this article come from The Claude Portfolio account on X, a third-party account not affiliated with Anthropic. It tracks how different AI models would trade if given a live portfolio. Claude AI recently added two names that couldn't …

Análisis y previsión de acciones de Marvell Technology Inc (MRVL)

Arvinas posts corporate presentation highlighting PROTAC degrader pipeline in oncology and neurology

Arvinas recently released a corporate presentation that highlights its PROTAC degrader pipeline, focusing on advancements in oncology and neurology. Key updates include the FDA clearance of VEPPANU for advanced breast cancer and the out-licensing of luxdegalutamide to Novartis, generating over $800 million in non-dilutive …

Arvind SmartSpaces Q1 Results: Profit zooms 8-fold to Rs 97 crore

HC Wainwright Has Pessimistic Outlook of Arvinas Q3 Earnings

Is Harvey Norman Holdings (ASX:HVN) Below Fair Value On The $35 Million ASIC Penalty?

Arvind SmartSpaces Reports Q1 Consolidated Net Profit of ₹99 Crore Vs ₹11.2 Crore YoY

Arvinas Inc (ARVN) Stock News Today

This article provides a current snapshot of Arvinas Inc (ARVN) stock information. It includes the latest stock price, market capitalization, and a note indicating that more news, earnings, and analyst ratings are coming soon. The page serves as a placeholder for future updates on …

First Modern Drill Test Lifts Marvel Gold (ASX:MVL) 8.33%

Select Harvests (SHV) Q4 2023 Earnings Report - Results, Call & Slides

Impressive Earnings May Not Tell The Whole Story For Carvana (NYSE:CVNA)

Aarvi Encon PAT surges 75% to ₹17.62 crore in FY26 on revenue growth

Enterprise value to revenue forward of Arvinas, Inc. – NASDAQ:ARVN

This article provides a financial snapshot for Arvinas, Inc. (NASDAQ: ARVN), focusing on its enterprise value to revenue forward. It appears to be a financial data point from TradingView, showing the period, value, and change for this specific metric. The content itself is very …

Aarvi Encon Q4 Results: Consolidated Net Profit Jumps 75.4% YoY to ₹1,762.05 lakhs

Orange Sky Golden Harvest Shifts Bermuda Registered Office While Keeping Hong Kong Share Services Unchanged

Marvell Technology Stock (MRVL) Opinions on Recent Earnings and AI Sector Trends

Carvana Co. 2026 Q2 - Results - Earnings Call Presentation (NYSE:CVNA) 2026-08-06

Pharvaris publishes study on rare angioedema condition

Pharvaris (NASDAQ:PHVS) announced the publication of a qualitative study on acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH) in Frontiers in Immunology. This study, the first in-depth assessment of the rare condition, highlighted frequent misdiagnoses, severe attacks, and significant life disruptions for patients who …

Why Marvell (MRVL) Is Up 29.1% After Launching Its New AI Memory Infrastructure Portfolio

Marvell Technology (MRVL) saw a 29.1% stock increase after launching its new AI memory infrastructure portfolio, including solutions for PCIe 6.0 SSD controllers, CXL-based memory expansion, and optical shared memory. These offerings aim to help hyperscalers enhance AI inference architectures by independently scaling memory …

Former penny stock nearing bankruptcy reports record profit

Carvana was once a stock that Wall Street wrote off. In December 2022, shares traded for less than $1 apiece (split-adjusted) after losing almost all their value in a single year. Bankruptcy talk was everywhere. Now the online used vehicle retailer is posting the …

Arvinas (NASDAQ:ARVN) Trading Down 7.8% on Analyst Downgrade

Arvinas (NASDAQ:ARVN) shares dropped 7.8% after Wells Fargo downgraded the stock from "overweight" to "equal weight." Despite this, the company reported a significant second-quarter beat with EPS of $2.58 and revenue of $249.7 million, largely due to licensing and milestone activities. Arvinas also received …

Carvana Co. (CVNA) VP sells 5,000 shares under Rule 10b5-1 plan

Carvana Co.'s Vice President of Accounting, Stephen R. Palmer, sold 5,000 shares of Class A Common Stock on August 3, 2026, across four transactions at volume-weighted average prices between $63.19 and $65.82 per share. These sales were conducted under a pre-arranged Rule 10b5-1 trading …

Carvana Co. (NYSE: CVNA) CEO reports 134,707-share award and tax withholding

Carvana Co.'s CEO, Ernest C. Garcia III, received an equity compensation award of 134,707 Class A Common Stock shares through restricted stock units. These units will vest 25% on April 1, 2027, with the remainder vesting monthly over the subsequent three years, contingent on …

Artemis Resources (ASX:ARV) Gains as New Funding Supports Gold and Copper Work

Arvinas Q2 2026 earnings: Licensing revenue drives a return to profit

Arvinas (ARVN) reported a significant turnaround in Q2 2026, driven by a surge in licensing revenue from its collaboration with Pfizer and the Rigel license agreement, leading to a profit of $2.58 diluted EPS. The company's revenue reached $249.7 million, up from $22.4 million …

Arvinas (ARVN) Stock Jumps As Profit Windfall Sparks Durability Debate

Arvinas (ARVN) stock surged 11.7% after reporting Q2 earnings, driven by a significant profit from licensing and collaboration revenue. Despite this windfall, concerns remain about the durability of its profit, as much of it was from one-off payments rather than recurring income, leading to …

Arvinas (ARVN) holder Noah C. Berkowitz plans sale of 30,000 shares

Noah C. Berkowitz, a shareholder of Arvinas (ARVN), has filed notice to sell 30,000 shares of common stock for an approximate aggregate price of $264,000 through Morgan Stanley. The filing also disclosed a previous sale of 24,000 shares on July 9, 2026, for $201,528. …

Arvinas (NASDAQ: ARVN) posts $169.4M profit on VEPPANU and Rigel deals

Arvinas (NASDAQ: ARVN) reported a significant financial turnaround in Q2 2026, posting a net income of $169.4 million and revenue of $249.7 million, compared to a net loss of $61.2 million and $22.4 million revenue in Q2 2025. This profitability was largely driven by …

Arvinas, Inc. Stock 12‑Month Price Target Cut to $14.85, Implies 84% Upside

Arvinas, Inc.'s average 12-month price target has been lowered from $15.08 to $14.85 by 13 analysts, with individual forecasts ranging from $6 to $24. This updated target suggests an 84% potential upside based on the Aug. 3 closing price. Despite the price target cut, …

ARVINAS, INC. 2026: Revenue $249.7M, EPS $2.58— 10-Q Summary

ARVINAS, INC. reported significant financial growth in 2026, with revenue reaching $249.7M and diluted EPS at $2.58, largely driven by licensing and milestone recognition. Key business highlights include FDA approval for VEPPANU and its out-license to Rigel, leading to substantial upfront and milestone payments. …

Carvana Co. (CVNA) CFO exercises options, sells 63,750 shares

Carvana Co.'s CFO, Mark W. Jenkins, exercised non-qualified stock options for 63,750 shares and subsequently sold all of them on August 3, 2026, for approximately $4.11 million. These transactions were carried out under a Rule 10b5-1 trading plan adopted in 2024. Additionally, Jenkins acquired …

Carvana (CVNA) grants 119,883 RSUs, withholds shares to pay taxes

Carvana's chief product officer, Daniel J. Gill, was granted 119,883 restricted stock units (RSUs) that will vest 25% on April 1, 2027, with the remainder vesting monthly over the next three years, contingent on his continued employment. Additionally, 7,707 shares were withheld at $62.36 …